Drug · DIN 02436779
ZYKADIA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since April 29, 2015; first marketed April 29, 2015.
- Drug Identification Number (DIN)
- 02436779
- Company (DIN owner)
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Ceritinib L01ED02
- Class
- Human
- Record last updated
- June 23, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CERITINIB | 150 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 27, 2015: NOC 16729New Drug Submission (NDS)